Spineway SA represents values of innovation, excellence, and patient-centricity. With a corporate philosophy focused on advancing spinal surgery solutions, Spineway SA is dedicated to improving patients' quality of life through pioneering and high-quality medical devices. The company's commitment to research and development, combined with a patient-centric approach, ensures that Spineway SA remains at the forefront of the spinal surgery industry. With a strong emphasis on innovation and a dedication to patient well-being, Spineway SA strives to shape the future of spinal surgery.

Spineway SA is primarily present in several countries and regions. The company has a significant presence in France, where it is headquartered, and is also actively involved in other European countries such as Germany, Spain, Italy, and the United Kingdom. Furthermore, Spineway SA has expanded its operations to various regions outside Europe, including Asia, the Middle East, Africa, and the Americas. With its growing global footprint, Spineway SA strives to bring its innovative spinal implant solutions to patients worldwide.

Spineway SA, a leading company in the medical device industry, has achieved several significant milestones. Over the years, the company has successfully developed and launched innovative spinal implant solutions, revolutionizing the treatment of spinal disorders. Spineway SA has expanded its global presence by securing partnerships and establishing a strong distribution network in key markets. Furthermore, the company has consistently delivered robust financial performance, showcasing its ability to generate sustainable growth and profitability. With a commitment to research and development, Spineway SA continues to introduce cutting-edge products and technologies, solidifying its position as a trusted and forward-thinking player in the industry.

Spineway SA is a renowned medical device company specializing in the design, manufacture, and distribution of surgical implants for treating spinal disorders. Established in [year], Spineway SA has a rich history in the field, with a strong focus on innovation and technological advancements. Over the years, the company has built a solid reputation for its high-quality products and commitment to improving patient outcomes. Spineway SA operates globally, collaborating with leading surgeons and healthcare professionals to provide advanced spinal solutions. With its dedication to research and development, Spineway SA remains at the forefront of the industry, delivering innovative and effective solutions for spinal treatments.

The main competitors of Spineway SA in the market include companies such as Medtronic, Zimmer Biomet, Johnson & Johnson, Stryker Corporation, and NuVasive.

Spineway SA is primarily active in the medical devices industry, specifically focusing on the design, manufacturing, and marketing of spinal surgery implants and instruments.

Spineway SA is a medical device company specializing in the design, development, and marketing of innovative implants and surgical instruments for the treatment of spinal disorders. The business model of Spineway SA revolves around providing cutting-edge spinal solutions to healthcare professionals and patients worldwide. Spineway SA focuses on designing and manufacturing high-quality, safe, and effective spinal implants that cater to the specific needs of surgeons and patients. By combining advanced technology, extensive research, and a customer-centric approach, Spineway SA aims to improve patient outcomes and enhance the overall treatment experience in the field of orthopedic surgery.

Spineway P/E-luku on 0,00.

Spineway KUV on 0,00.

AlleAktien Laatuscore Spineway on 6/10.

odotettu Spineway liikevaihto on 8,85 milj. EUR.

odotettu Spineway voitto on 54,91 milj. EUR.

Spineway SA is a leading manufacturer of implants for spinal surgery. The company was founded in France in 2005 and now has production facilities in Europe, Asia, and America. It is listed on the French stock exchange and is one of the most innovative and fast-growing companies in the industry.

Spineway maksaa osinkoa 0 EUR, joka jaetaan erässä vuoden aikana.

Osinkoa ei voida tällä hetkellä laskea Spineway:lle tai yhtiö ei maksa osinkoa.

Spineway:n ISIN on FR0011398874.

Spineway:n WKN on A1KCX1.

Spineway:n tunnus on ALSPW.PA.

Viimeisen 12 kuukauden aikana Spineway maksoi osinkoa edestä. Tämä vastaa noin osinkotuottoa. Seuraavan 12 kuukauden aikana Spineway maksanee ennusteiden mukaan 0 EUR osingon.

Spineway:n tämänhetkinen osinkotuotto on .

Spineway maksaa osinkoa neljännesvuosittain. Osingot jaetaan kuukausina .

Spineway maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Seuraavalle 12 kuukaudelle odotetaan 0 EUR suuruisia osinkoja. Tämä vastaa 0 % osinkotuottoa.

Spineway kuuluu sektoriin 'Terveys'.

Saadaksesi viimeisimmän Spineway osingon 19.9.2024, jonka suuruus on 0 EUR, sinun oli oltava omistanut osakkeen ennen ex-päivää, joka oli 19.9.2024.

Viimeisin osinko maksettiin 19.9.2024.

Vuonna 2023 Spineway maksoi 0 EUR osinkoina.

Spineway:n osingot maksetaan EURssa.